Emerging and established biomarkers of oculopharyngeal muscular dystrophy
Neuromuscular Disorders · 2023-11 · 33 (11) · 824-834
DOI: 10.1016/j.nmd.2023.09.010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuromuscular Disorders, 2023-11. Verfasst von Ian C Smith und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Ottawa Hospital Research Institute, Ottawa, ON K1Y 4E9, Canada. Hauptthemen laut MEDLINE: Muscular Dystrophy, Oculopharyngeal, Deglutition Disorders, Blepharoptosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 153 Literaturangaben.
Abstract (Originalsprache)
Oculopharyngeal muscular dystrophy (OPMD) is a rare, primarily autosomal dominant, late onset muscular dystrophy commonly presenting with ptosis, dysphagia, and subsequent weakness of proximal muscles. Although OPMD diagnosis can be confirmed with high confidence by genetic testing, the slow progression of OPMD poses a significant challenge to clinical monitoring and a barrier to assessing the efficacy of treatments during clinical trials. Accordingly, there is a pressing need for more sensitive measures of OPMD progression, particularly those which do not require a muscle biopsy. This review provides an overview of progress in OPMD biomarkers from clinical assessment, quantitative imaging, histological assessments, and genomics, as well as hypothesis-generating "omics" approaches. The ongoing search for biomarkers relevant to OPMD progression needs an integrative, longitudinal approach combining validated and experimental approaches which may include clinical, imaging, demographic, and biochemical assessment methods. A multi-omics approach to biochemical biomarker discovery could help provide context for differences found between individuals with varying levels of disease activity and provide insight into pathomechanisms and prognosis of OPMD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Ottawa Hospital Research Institute, Ottawa, ON K1Y 4E9, Canada.
- Faculty of Science, University of Ottawa, Ottawa, ON K1N 9B4, Canada.
- Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada; Department of Medicine, The Ottawa Hospital/University of Ottawa, Ottawa, ON K1H 8L6, Canada; Eric Poulin Centre for Neuromuscular Disease, Universi…
- Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada; Eric Poulin Centre for Neuromuscular Disease, University of Ottawa, Ottawa, ON K1Y 4E9, Canada; Department of Medical Imaging, The Ottawa Hospital,…
- The Ottawa Hospital Research Institute, Ottawa, ON K1Y 4E9, Canada; Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada; Department of Medicine, The Ottawa Hospital/University of Ottawa, Ottawa, ON K1H…
- The Ottawa Hospital Research Institute, Ottawa, ON K1Y 4E9, Canada; Eric Poulin Centre for Neuromuscular Disease, University of Ottawa, Ottawa, ON K1Y 4E9, Canada; Department of Pathology and Laboratory Medicine, The Ot…
Zitieren
APA
Smith, I. C., Chakraborty, S., Bourque, P. R., Sampaio, M. L., Melkus, G., Lochmüller, H., Woulfe, J., Parks, R. J., Brais, B., & Warman-Chardon, J. (2023). Emerging and established biomarkers of oculopharyngeal muscular dystrophy. Neuromuscular Disorders, 33(11), 824-834. https://doi.org/10.1016/j.nmd.2023.09.010
Vancouver
Smith IC, Chakraborty S, Bourque PR, Sampaio ML, Melkus G, Lochmüller H, et al. Emerging and established biomarkers of oculopharyngeal muscular dystrophy. Neuromuscular Disorders. 2023;33(11):824-834. doi:10.1016/j.nmd.2023.09.010
BibTeX
@article{Smith2023,
author = {Smith, Ian C and Chakraborty, Shaoni and Bourque, Pierre R and Sampaio, Marcos L and Melkus, Gerd and Lochmüller, Hanns and Woulfe, John and Parks, Robin J and Brais, Bernard and Warman-Chardon, Jodi},
title = {Emerging and established biomarkers of oculopharyngeal muscular dystrophy},
journal = {Neuromuscular Disorders},
year = {2023},
volume = {33},
number = {11},
pages = {824--834},
doi = {10.1016/j.nmd.2023.09.010}
}
EUVIMED